Literature DB >> 16624944

Reversal of brain injury-induced prefrontal glutamic acid decarboxylase expression and working memory deficits by D1 receptor antagonism.

Nobuhide Kobori1, Pramod K Dash.   

Abstract

Working memory (WM), the ability to transiently hold information in mind, is essential for high-level cognitive functions that are often impaired in brain-injured patients. The cellular and molecular mechanisms contributing to WM deficits, which can manifest in the absence of overt damage, in these patients are unknown. The function of the dorsolateral prefrontal cortex in humans and monkeys, and the medial prefrontal cortex (mPFC), in rodents is critical for WM. We demonstrate that controlled cortical impact injury of rats causes a long-lasting WM impairment that is associated with increased levels of the GABA-synthesizing enzyme glutamic acid decarboxylase 67 (GAD67) in the mPFC for up to 1 month after injury. A single administration of dopamine D1 antagonists at 14 d after injury is sufficient to decrease GAD67 levels and restore WM for at least 1 week. These findings indicate that inhibition of prefrontal neuronal activity contributes to WM deficits and that strategies to reduce GAD67 expression can offer prolonged WM improvement in brain-injured patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624944      PMCID: PMC6673989          DOI: 10.1523/JNEUROSCI.4687-05.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  30 in total

1.  Targeting Dopamine in Acute Traumatic Brain Injury.

Authors:  James W Bales; Anthony E Kline; Amy K Wagner; C Edward Dixon
Journal:  Open Drug Discov J       Date:  2010

2.  Changes in cortical plasticity after mild traumatic brain injury.

Authors:  Shahid Bashir; Marine Vernet; Woo-Kyoung Yoo; Ilan Mizrahi; Hugo Theoret; Alvaro Pascual-Leone
Journal:  Restor Neurol Neurosci       Date:  2012       Impact factor: 2.406

3.  Altered adrenergic receptor signaling following traumatic brain injury contributes to working memory dysfunction.

Authors:  N Kobori; B Hu; P K Dash
Journal:  Neuroscience       Date:  2010-10-23       Impact factor: 3.590

4.  GAD67-mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex.

Authors:  Bidisha Chattopadhyaya; Graziella Di Cristo; Cai Zhi Wu; Graham Knott; Sandra Kuhlman; Yu Fu; Richard D Palmiter; Z Josh Huang
Journal:  Neuron       Date:  2007-06-21       Impact factor: 17.173

Review 5.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 6.  Activity-dependent development of inhibitory synapses and innervation pattern: role of GABA signalling and beyond.

Authors:  Z Josh Huang
Journal:  J Physiol       Date:  2009-02-02       Impact factor: 5.182

7.  Quantification of D1 and D5 dopamine receptor localization in layers I, III, and V of Macaca mulatta prefrontal cortical area 9: coexpression in dendritic spines and axon terminals.

Authors:  Jill R Bordelon-Glausier; Zafar U Khan; E Chris Muly
Journal:  J Comp Neurol       Date:  2008-06-20       Impact factor: 3.215

8.  Altered regulation of protein kinase a activity in the medial prefrontal cortex of normal and brain-injured animals actively engaged in a working memory task.

Authors:  Nobuhide Kobori; Anthony N Moore; Pramod K Dash
Journal:  J Neurotrauma       Date:  2014-11-13       Impact factor: 5.269

Review 9.  Pathophysiology and Treatment of Memory Dysfunction After Traumatic Brain Injury.

Authors:  Rosalia Paterno; Kaitlin A Folweiler; Akiva S Cohen
Journal:  Curr Neurol Neurosci Rep       Date:  2017-07       Impact factor: 5.081

10.  Restoration of neuroendocrine stress response by glucocorticoid receptor or GABA(A) receptor antagonists after experimental traumatic brain injury.

Authors:  Anna N Taylor; Delia L Tio; Richard L Sutton
Journal:  J Neurotrauma       Date:  2013-06-27       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.